首页 > 最新文献

Reviews in Gynaecological and Perinatal Practice最新文献

英文 中文
Religious aspects of contraception 避孕的宗教方面
Pub Date : 2006-09-01 DOI: 10.1016/j.rigapp.2006.05.003
Elphis Christopher

After an introduction recounting the pronatalist views of the world's religions, the article goes on to explore each of the major religions, Judaism, Christianity, Islam, Hinduism, Sikhism and Buddhism and their belief systems in relation to contraception and abortion. This is followed by a discussion of the practical consequences of these beliefs and of the role of the professional in helping women and couples of the varied faiths in their choice of methods. How these choices may affect religious practices and vice versa is also considered.

在介绍了世界各宗教的生育主义观点之后,文章继续探讨了犹太教、基督教、伊斯兰教、印度教、锡克教和佛教等主要宗教及其与避孕和堕胎有关的信仰体系。随后讨论了这些信仰的实际后果,以及专业人员在帮助不同信仰的妇女和夫妇选择方法方面的作用。这些选择如何影响宗教习俗,反之亦然也被考虑。
{"title":"Religious aspects of contraception","authors":"Elphis Christopher","doi":"10.1016/j.rigapp.2006.05.003","DOIUrl":"10.1016/j.rigapp.2006.05.003","url":null,"abstract":"<div><p>After an introduction recounting the pronatalist views of the world's religions, the article goes on to explore each of the major religions, Judaism, Christianity, Islam, Hinduism, Sikhism and Buddhism and their belief systems in relation to contraception and abortion. This is followed by a discussion of the practical consequences of these beliefs and of the role of the professional in helping women and couples of the varied faiths in their choice of methods. How these choices may affect religious practices and vice versa is also considered.</p></div>","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigapp.2006.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91553768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Management of postpartum urinary retention 产后尿潴留的处理
Pub Date : 2006-09-01 DOI: 10.1016/j.rigapp.2006.02.003
Raheela M. Rizvi, Javed Rizvi

There is a large body of literature investigating the mechanism, risk factors, and pathophysiology of postpartum urinary retention; it is usually a temporary condition where early diagnosis and appropriate management can avoid long term complication. This article reviews the etiology, prevention, management and long-term implications of retention for bladder functions.

有大量的文献研究产后尿潴留的机制、危险因素和病理生理;它通常是一种暂时性疾病,早期诊断和适当的治疗可以避免长期并发症。本文综述了膀胱功能潴留的病因、预防、处理和长期影响。
{"title":"Management of postpartum urinary retention","authors":"Raheela M. Rizvi,&nbsp;Javed Rizvi","doi":"10.1016/j.rigapp.2006.02.003","DOIUrl":"10.1016/j.rigapp.2006.02.003","url":null,"abstract":"<div><p>There is a large body of literature investigating the mechanism, risk factors, and pathophysiology of postpartum urinary retention; it is usually a temporary condition where early diagnosis and appropriate management can avoid long term complication. This article reviews the etiology, prevention, management and long-term implications of retention for bladder functions.</p></div>","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigapp.2006.02.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85455840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Treatment and follow-up of women with microinvasive cervical cancer 微创宫颈癌妇女的治疗与随访
Pub Date : 2006-09-01 DOI: 10.1016/j.rigapp.2006.05.001
Mary Cairns, Margaret Cruickshank

Until recently, the treatment of choice for Stage 1A cervical cancer has been simple or radical hysterectomy. With excellent survival rates and an increasing desire to conserve fertility, conservative surgical methods are being used. The object of this review is to discuss prognostic factors, treatment options and methods of follow-up for women with microinvasive cervical cancer.

直到最近,1A期宫颈癌的治疗选择一直是简单或根治性子宫切除术。随着生存率的提高和保留生育能力的愿望的增加,保守的手术方法被使用。本综述的目的是讨论妇女微创宫颈癌的预后因素、治疗方案和随访方法。
{"title":"Treatment and follow-up of women with microinvasive cervical cancer","authors":"Mary Cairns,&nbsp;Margaret Cruickshank","doi":"10.1016/j.rigapp.2006.05.001","DOIUrl":"10.1016/j.rigapp.2006.05.001","url":null,"abstract":"<div><p>Until recently, the treatment of choice for Stage 1A cervical cancer has been simple or radical hysterectomy<span>. With excellent survival rates and an increasing desire to conserve fertility, conservative surgical methods are being used. The object of this review is to discuss prognostic factors, treatment options and methods of follow-up for women with microinvasive cervical cancer.</span></p></div>","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigapp.2006.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87706994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Editorial Board and Aims and Scope 编辑委员会和目标和范围
Pub Date : 2006-09-01 DOI: 10.1016/S1871-2320(06)00032-0
{"title":"Editorial Board and Aims and Scope","authors":"","doi":"10.1016/S1871-2320(06)00032-0","DOIUrl":"https://doi.org/10.1016/S1871-2320(06)00032-0","url":null,"abstract":"","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1871-2320(06)00032-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137222520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Index of Volume 6 第6卷作者索引
Pub Date : 2006-09-01 DOI: 10.1016/S1871-2320(06)00037-X
{"title":"Author Index of Volume 6","authors":"","doi":"10.1016/S1871-2320(06)00037-X","DOIUrl":"https://doi.org/10.1016/S1871-2320(06)00037-X","url":null,"abstract":"","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1871-2320(06)00037-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137222659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endometriosis: A general review and rationale for surgical therapy 子宫内膜异位症:手术治疗的综述和基本原理
Pub Date : 2006-09-01 DOI: 10.1016/j.rigapp.2006.05.005
P. Barton-Smith , K. Ballard , A.S.H. Kent

This review article aims to give a comprehensive insight into both the historical and current thoughts on all aspects of endometriosis including aetiology, diagnosis, and medical and surgical treatments. The prevalence of endometriosis is about 6–8%, and may affect up to two million women in the United Kingdom. It causes, through pain and infertility, a significant problem for sufferers, their families and society as a whole. There is no conclusive evidence to explain its aetiology although our understanding of the basic pathophysiology is improving. However, there remains a substantial lack of understanding in all areas of disease.

A rationale is presented for surgical therapy as the preferred approach for diagnosis and treatment. The recognised gold standard for diagnosis is laparoscopy. Surgery is the only treatment modality that consistently eradicates all macroscopic diseases and can be carried out at the same time as diagnosis. There is no evidence that medical treatment is superior to surgical treatment. Surgical removal of endometriotic lesions is the only treatment that improves spontaneous conception rates in endometriosis-associated infertility. The evidence for the surgical techniques and energy modalities used for the surgical management of minimal to moderate endometriosis, endometriomas and recto-vaginal disease are described in greater detail.

本文综述了子宫内膜异位症的历史和现状,包括病因、诊断、医学和外科治疗。子宫内膜异位症的患病率约为6-8%,在英国可能影响多达200万妇女。通过疼痛和不育,它给患者、他们的家庭和整个社会带来了一个重大问题。虽然我们对其基本病理生理学的认识在不断提高,但没有确凿的证据来解释其病因。然而,对所有疾病领域的了解仍然严重不足。提出了手术治疗作为诊断和治疗的首选方法的基本原理。公认的诊断金标准是腹腔镜检查。手术是唯一能持续根除所有宏观疾病并能与诊断同时进行的治疗方式。没有证据表明药物治疗优于手术治疗。手术切除子宫内膜异位症病变是提高子宫内膜异位症相关不孕症的自然受孕率的唯一治疗方法。更详细地描述了用于轻度至中度子宫内膜异位症、子宫内膜异位症和直肠阴道疾病手术治疗的手术技术和能量模式的证据。
{"title":"Endometriosis: A general review and rationale for surgical therapy","authors":"P. Barton-Smith ,&nbsp;K. Ballard ,&nbsp;A.S.H. Kent","doi":"10.1016/j.rigapp.2006.05.005","DOIUrl":"10.1016/j.rigapp.2006.05.005","url":null,"abstract":"<div><p>This review article aims to give a comprehensive insight into both the historical and current thoughts on all aspects of endometriosis<span><span> including aetiology, diagnosis, and medical and surgical treatments. The prevalence of endometriosis is about 6–8%, and may affect up to two million women in the United Kingdom. It causes, through pain and infertility, a significant problem for sufferers, their families and society as a whole. There is no conclusive evidence to explain its aetiology although our understanding of the basic </span>pathophysiology is improving. However, there remains a substantial lack of understanding in all areas of disease.</span></p><p>A rationale is presented for surgical therapy as the preferred approach for diagnosis and treatment. The recognised gold standard for diagnosis is laparoscopy. Surgery is the only treatment modality that consistently eradicates all macroscopic diseases and can be carried out at the same time as diagnosis. There is no evidence that medical treatment is superior to surgical treatment. Surgical removal of endometriotic lesions is the only treatment that improves spontaneous conception rates in endometriosis-associated infertility. The evidence for the surgical techniques and energy modalities used for the surgical management of minimal to moderate endometriosis, endometriomas and recto-vaginal disease are described in greater detail.</p></div>","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigapp.2006.05.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84927808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Antenatal prevention of neonatal group B streptococcal infection 新生儿B群链球菌感染的产前预防
Pub Date : 2006-09-01 DOI: 10.1016/j.rigapp.2006.05.006
Sophie Beal , Stephanie Dancer

Group B streptococci can be isolated from the vagina of 15–40% of pregnant women. Vertical transmission to the infant occurs in 50% of deliveries involving colonised women. Most infants remain asymptomatic, but 1–2% develop clinical infection, which is associated with significant morbidity and mortality. Vertical transmission can be successfully prevented by intrapartum administration of antibiotics. Other proposed methods include vaccines and intrapartum vaginal or neonatal washing with antiseptics.

Selection of women for prophylactic antibiotics can be based on risk factors, screening or a combination of both. Benefits of prophylaxis should be balanced against cost, medicalisation of labour and the risks of anaphylaxis and bacterial resistance.

We present an overview of vaginal group B streptococcal isolation methods and antenatal strategies for prevention of neonatal infection.

B群链球菌可从15-40%的孕妇阴道中分离出来。在殖民地妇女分娩时,50%的婴儿发生垂直传播。大多数婴儿仍无症状,但1-2%会发生临床感染,这与显著的发病率和死亡率相关。产时给予抗生素可成功防止垂直传播。其他建议的方法包括疫苗和产时阴道或新生儿用防腐剂清洗。为妇女选择预防性抗生素可基于风险因素、筛查或两者结合。预防的益处应与成本、劳动力的医疗化以及过敏反应和细菌耐药性的风险相平衡。我们提出了阴道B群链球菌分离方法和产前策略预防新生儿感染的概述。
{"title":"Antenatal prevention of neonatal group B streptococcal infection","authors":"Sophie Beal ,&nbsp;Stephanie Dancer","doi":"10.1016/j.rigapp.2006.05.006","DOIUrl":"10.1016/j.rigapp.2006.05.006","url":null,"abstract":"<div><p><span>Group B streptococci can be isolated from the vagina of 15–40% of pregnant women. Vertical transmission to the infant occurs in 50% of deliveries involving colonised women. Most infants remain asymptomatic, but 1–2% develop clinical infection, which is associated with significant morbidity and mortality. Vertical transmission can be successfully prevented by </span>intrapartum administration of antibiotics. Other proposed methods include vaccines and intrapartum vaginal or neonatal washing with antiseptics.</p><p>Selection of women for prophylactic antibiotics can be based on risk factors, screening or a combination of both. Benefits of prophylaxis should be balanced against cost, medicalisation of labour and the risks of anaphylaxis and bacterial resistance.</p><p>We present an overview of vaginal group B streptococcal isolation methods and antenatal strategies for prevention of neonatal infection.</p></div>","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigapp.2006.05.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81544535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Optimising in vitro fertilisation (IVF) outcome in women with endometriosis 子宫内膜异位症女性体外受精(IVF)结果的优化
Pub Date : 2006-09-01 DOI: 10.1016/j.rigapp.2006.05.008
Alejandro Chavez-Badiola, Andrew Drakeley

The etiology of endometriosis remains unclear and at the moment most of the therapeutic options are directed towards the relief of symptoms. In this context, in vitro fertilisation (IVF) overcomes anatomical distortion but our ability to influence environmental factors still seems to be limited. The improvement in pregnancy rates in endometriosis associated infertility is as important as the reduction in complications, and a careful analysis for the indications of each treatment option should be guaranteed. The use of gonadotropin releasing hormone agonists (GnRHa) for 3–6 months has shown to improve IVF outcomes, while increasing literature questions the role of surgery prior to the start of an IVF treatment cycle in views of fertility improvement. Early referral of these women to specialised centres is advised.

子宫内膜异位症的病因尚不清楚,目前大多数治疗选择都是针对症状的缓解。在这种情况下,体外受精(IVF)克服了解剖畸变,但我们影响环境因素的能力似乎仍然有限。改善子宫内膜异位症相关不孕症的妊娠率与减少并发症同样重要,应确保对每种治疗方案的适应症进行仔细分析。使用促性腺激素释放激素激动剂(GnRHa) 3-6个月已显示可改善体外受精结果,但越来越多的文献质疑在体外受精治疗周期开始前手术在改善生育能力方面的作用。建议将这些妇女及早转介到专门中心。
{"title":"Optimising in vitro fertilisation (IVF) outcome in women with endometriosis","authors":"Alejandro Chavez-Badiola,&nbsp;Andrew Drakeley","doi":"10.1016/j.rigapp.2006.05.008","DOIUrl":"10.1016/j.rigapp.2006.05.008","url":null,"abstract":"<div><p>The etiology of endometriosis<span> remains unclear and at the moment most of the therapeutic options are directed towards the relief of symptoms. In this context, in vitro fertilisation<span> (IVF) overcomes anatomical distortion but our ability to influence environmental factors still seems to be limited. The improvement in pregnancy rates in endometriosis associated infertility<span> is as important as the reduction in complications, and a careful analysis for the indications of each treatment option should be guaranteed. The use of gonadotropin releasing hormone agonists (GnRHa) for 3–6 months has shown to improve IVF outcomes, while increasing literature questions the role of surgery prior to the start of an IVF treatment cycle in views of fertility improvement. Early referral of these women to specialised centres is advised.</span></span></span></p></div>","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigapp.2006.05.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80785876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A systematic review to determine the effectiveness of medical therapies at causing disease regression in endometriosis 确定药物治疗在引起子宫内膜异位症疾病消退方面的有效性的系统综述
Pub Date : 2006-09-01 DOI: 10.1016/j.rigapp.2006.05.002
T.T. Carpenter , A.S.H. Kent , R. Lawrenson

Endometriosis is a common condition affecting around 2–10% of women of reproductive age. Various medical therapies are in widespread use for control of symptoms, however, very little is known of the effect of these therapies on the disease itself. In addition, the natural history of the condition when left untreated is far from clearly understood. If one uses medical therapies for symptom control it is possible the underlying disease may progress insidiously such that, if surgery is required in the future, may be increasingly difficult and hazardous. We reviewed the literature to assess the efficacy of any medically treatment used in endometriosis at causing regression of disease. Despite an extensive search, this issue is addressed adequately by very few studies. The data that are available suggests medroxyprogesterone acetate (MPA) and luteal phase dydrogesterone are probably ineffective at causing disease regression whilst gestrinone appears to be effective. The effects of danazol and triptorelin are inconclusive.

子宫内膜异位症是一种常见的疾病,影响约2-10%的育龄妇女。各种医学疗法被广泛用于控制症状,然而,很少知道这些疗法对疾病本身的影响。此外,如果不及时治疗,这种疾病的自然史还远没有被清楚地了解。如果一个人使用药物治疗来控制症状,那么潜在的疾病可能会在不知不觉中发展,这样,如果将来需要手术,可能会越来越困难和危险。我们回顾了文献,以评估任何用于子宫内膜异位症的药物治疗在引起疾病消退方面的疗效。尽管进行了广泛的研究,但很少有研究充分地解决了这个问题。现有的数据表明醋酸甲羟孕酮和黄体相地孕酮在引起疾病消退方面可能无效,而孕酮似乎有效。那那唑和雷普妥林的效果尚无定论。
{"title":"A systematic review to determine the effectiveness of medical therapies at causing disease regression in endometriosis","authors":"T.T. Carpenter ,&nbsp;A.S.H. Kent ,&nbsp;R. Lawrenson","doi":"10.1016/j.rigapp.2006.05.002","DOIUrl":"10.1016/j.rigapp.2006.05.002","url":null,"abstract":"<div><p><span>Endometriosis<span> is a common condition affecting around 2–10% of women of reproductive age. Various medical therapies are in widespread use for control of symptoms, however, very little is known of the effect of these therapies on the disease itself. In addition, the natural history of the condition when left untreated is far from clearly understood. If one uses medical therapies for symptom control it is possible the underlying disease may progress insidiously such that, if surgery is required in the future, may be increasingly difficult and hazardous. We reviewed the literature to assess the efficacy of any medically treatment used in endometriosis at causing regression of disease. Despite an extensive search, this issue is addressed adequately by very few studies. The data that are available suggests medroxyprogesterone acetate<span> (MPA) and luteal phase dydrogesterone<span> are probably ineffective at causing disease regression whilst </span></span></span></span>gestrinone<span> appears to be effective. The effects of danazol<span> and triptorelin are inconclusive.</span></span></p></div>","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigapp.2006.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83284764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Laparoscopy in gynaecological oncological surgery in 2005 腹腔镜在妇科肿瘤手术中的应用
Pub Date : 2006-06-01 DOI: 10.1016/j.rigapp.2005.12.002
Marie Claude Renaud, Michel Roy

Laparoscopy entered the field of gynaecology in the mid-1950s, but the technique was slow to evolve until the beginning of the 1990s, when it became more widely applied in gynecological oncology. Although few trials have looked at the safety of laparoscopy in oncology, it is now widely used for most gynaecological malignancies. Cervical cancer has probably the strongest literature devoted to it, and so far this does not seem to demonstrate a detrimental survival profile. Uterine cancer relies on laparoscopy for the initial surgery or staging of an unstaged patient. In ovarian cancer, the technique is mostly used in early cases for staging purposes, or in advanced cases before neoadjuvant chemotherapy. Trocar metastasis is probably not as frequent as initially suggested, but good surgical technique is of paramount importance in preventing this. Although laparoscopy is very promising and probably oncologically safe, and although there are few published prospective trials, the technique demands satisfactory additional training and, in the setting of gynaecological cancers, should be reserved for trained subspecialists.

腹腔镜在20世纪50年代中期进入妇科领域,但该技术发展缓慢,直到20世纪90年代初才在妇科肿瘤学中得到更广泛的应用。虽然很少有试验关注腹腔镜在肿瘤中的安全性,但它现在被广泛用于大多数妇科恶性肿瘤。关于子宫颈癌的文献可能是最多的,到目前为止,这似乎并没有显示出有害的生存状况。子宫癌依靠腹腔镜进行初始手术或对未分期的患者进行分期。在卵巢癌中,该技术主要用于早期病例的分期目的,或用于新辅助化疗前的晚期病例。套管针转移可能不像最初认为的那样频繁,但良好的手术技术对预防这种情况至关重要。虽然腹腔镜检查很有前途,而且可能在肿瘤方面是安全的,虽然发表的前瞻性试验很少,但这项技术需要令人满意的额外培训,并且在妇科癌症的情况下,应该保留给训练有素的专科医生。
{"title":"Laparoscopy in gynaecological oncological surgery in 2005","authors":"Marie Claude Renaud,&nbsp;Michel Roy","doi":"10.1016/j.rigapp.2005.12.002","DOIUrl":"10.1016/j.rigapp.2005.12.002","url":null,"abstract":"<div><p>Laparoscopy entered the field of gynaecology<span><span> in the mid-1950s, but the technique was slow to evolve until the beginning of the 1990s, when it became more widely applied in gynecological oncology. Although few trials have looked at the safety of laparoscopy in oncology, it is now widely used for most gynaecological malignancies. Cervical cancer has probably the strongest literature devoted to it, and so far this does not seem to demonstrate a detrimental survival profile. Uterine cancer relies on laparoscopy for the initial surgery or staging of an unstaged patient. In ovarian cancer, the technique is mostly used in early cases for staging purposes, or in advanced cases before </span>neoadjuvant chemotherapy<span><span>. Trocar metastasis is probably not as frequent as initially suggested, but good surgical technique is of paramount importance in preventing this. Although laparoscopy is very promising and probably oncologically safe, and although there are few published prospective trials, the technique demands satisfactory additional training and, in the setting of </span>gynaecological cancers, should be reserved for trained subspecialists.</span></span></p></div>","PeriodicalId":101088,"journal":{"name":"Reviews in Gynaecological and Perinatal Practice","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigapp.2005.12.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73979255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Reviews in Gynaecological and Perinatal Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1